Free press releases distribution network?

Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Elham Behshad, Incyte to Speak on cMET HTS at 6th Protein Kinase Conference May 26-27, Boston - Elham Behshad, Ph.D., Principal Investigator at Incyte to give a presentation on a collaboration with Novartis titled “Phosphorylation State and Compound Selectivity; c-Met HTS as Case Study” at GTCbio’s 6th Protein Kinases Conference
Elham Behshad, Incyte to Speak on cMET HTS at 6th Protein Kinase Conference May 26-27, Boston

 

PRZOOM - /newswire/ - Monrovia, CA, United States, 2011/03/21 - Elham Behshad, Ph.D., Principal Investigator at Incyte to give a presentation on a collaboration with Novartis titled “Phosphorylation State and Compound Selectivity; c-Met HTS as Case Study” at GTCbio’s 6th Protein Kinases Conference.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Elham Behshad, Ph.D., to give a presentation on a collaboration with Novartis titled “Phosphorylation State and Compound Selectivity; c-Met HTS as Case Study” at GTCbio’s 6th Protein Kinases in Drug Discovery Conference on May 26-27, 2011 in Boston, MA.

Dr. Behshad will discuss a collaboration project with Novartis as Phase I trials begin for a c-MET inhibitor named INCB28060 that could successfully overcome drug resistance in lung, kidney and gastric cancers.

This meeting will offer you an intimate forum to engage in discourse with industry leaders from major pharmaceutical companies, biotech companies as well as top researchers from academia and government regarding the complex activities of kinases and cutting-edge solutions to the challenges associated with kinase drug development.

Notable presenters include Keith T. Flaherty, M.D., Principal Investigator and Director of Developmental Therapeutics at Massachusetts General Hospital Cancer Center; Nathanael S. Gray, Ph.D., Principal Investigator of Biological Chemistry and Molecular Pharmacology at Dana Farber Cancer Institute; William C. Shakespeare, Ph.D., Vice President, Drug Discovery at ARIAD Pharmaceuticals; and Marcie A. Glicksman, Ph.D., Co-Director, Laboratory for Drug Discovery at Harvard Neurodiscovery Center.

Also presenting at the Protein Kinase Conference are scientists from prestigious organizations including Abbott, Amgen, Ansaris, ArQule, Avila Tx, Biogen Idec, Broad Institute, Dana Farber, DE Shaw Research, Genentech, Harvard Neurodiscovery Center, Mass Gen Hospital, Millennium, Merck, Novartis, OSI Pharma, Pfizer, and other leaders in the kinase industry.

For more information, please visit gtcbio.com/.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Elham Behshad, Incyte to Speak on cMET HTS at 6th Protein Kinase Conference May 26-27, Boston

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  MagLar, Inc.

Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today